Description
The suspension of trading in the securities of Arovella Therapeutics Limited (‘ALA’) will be lifted immediately, following the release by ALA of an announcement in relation to a proposed in-licensing agreement.
Issued by
Scarlette de Lavaine
Adviser, Listings Compliance (Perth)
For more information, download the attached PDF.
Download this document
